Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data
Go back to Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.31 +0.08 (1.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.23 | 52 Week High | $45.34 | |||
| Open | $4.28 | 52 Week Low | $15.92 | |||
| Day High | $4.39 | P/E | 1.85 | |||
| Day Low | $4.22 | EPS | $2.33 | |||
| Volume | 1,504,794 | |||||
